Clinical Evaluation of Low Sodium Peritoneal Dialysis (PD) Solution on Hypertensive Patients Treated With PD

Inclusion Criteria: * Chronic renal failure * Stable patients on PD treatment * Treatment at the study site for at least three months * Treated in a CAPD program with a minimum of 3 bag exchanges with 6 or 7 days per week including at least one with duration of 4-6 hours, and at least one low strength bag per day, or in an APD program with at least one daytime exchange with duration of 4-6 hours using one low strength bag * Hypertensive patients with high blood pressure at inclusion visit (Office SBP ≥ 140 and/or DBP ≥ 90 mmHg) or hypertensive patients receiving anti hypertensive medication including diuretics, disregarded blood pressure values * Patients aged 18 years or more * Written consent to participate in the study (informed consent) * Able to use a three-compartment bag * Life expectancy and expected technical survival ≥ 9 months Exclusion Criteria: * Low blood pressure (Office sitting SBP ≤ 120 mmHg and confirmed by ABPM \< or = to 105 mean 24h SBP) * Orthostatic hypotension defined as Systolic OBP with a drop of \> 20mmHg and symptomatic after standing for at least 1 minute * Natremia \< 130 mmol/l, after two consecutive measurements * Chronic arrhythmia * Pregnancy or lactation * Participation in other studies during the study period which may affect the outcome of the present study * Peritonitis within one month prior to the study start * Exit site and /or tunnel infection * Patients unable to tolerate 2 L bag exchanges * Patients on non-compatible PD system